Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07675499 · ClinicalTrials.gov registry record · Phase 2
Exercise and Intranasal Insulin in Type 2 Diabetes
A Phase 2 study, sponsored by Rutgers, The State University of New Jersey.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 60
- Enrollment target
NCT07675499 is a Phase 2 study that is actively recruiting participants, run by Rutgers, The State University of New Jersey. The registered enrollment target is 60 participants.
The verdict
NCT07675499, a Phase 2 study, is actively recruiting participants, sponsored by Rutgers, The State University of New Jersey.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 60 participants
- Enrollment target
Study Summary
About 6.5 million adults in the United States who are 65 or older have dementia. While the exact cause of dementia is not known, it may be due to changes in the brain. Further, risk may be higher when the brain does not respond to insulin. Indeed, brain insulin resistance has emerged as a pathologic factor affecting memory, executive function as well as systemic glucose control. Regular aerobic exercise may help reduce the risk of dementia by increased blood flow to the brain and help the brain respond better to insulin. In addition, giving insulin through a nose spray (called intranasal insulin) may also help with thinking and memory. However, it is unknown if using both exercise and intranasal insulin is best for the brain.
Interventions
- BEHAVIORAL High Intensity Exercise
- DRUG Intranasal Insulin
- DRUG Intranasal Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2026-08-03 |
| Est. Completion | 2029-05-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07675499
The ClinicalTrials.gov registry entry for NCT07675499 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which High Intensity Exercise is the first listed.
NCT07675499 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07675499 about?
NCT07675499 is a clinical study titled "Exercise and Intranasal Insulin in Type 2 Diabetes". About 6.5 million adults in the United States who are 65 or older have dementia. While the exact cause of dementia is not known, it may be due to changes in the brain. Further, risk may be higher when the brain does not respond to insulin. Indeed, brain insulin resistance has emerged as a pathologi...
What is the current status of trial NCT07675499?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2026-08-03. Estimated completion is 2029-05-31.
What interventions are being tested in trial NCT07675499?
The interventions under investigation include: High Intensity Exercise (BEHAVIORAL), Intranasal Insulin (DRUG), Intranasal Placebo (DRUG).
Who is sponsoring clinical trial NCT07675499?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.